Suchergebnisse - Walmsley, Charlotte
- Treffer 1 - 8 von 8
-
1
-
2
The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression von Elaimy, Ameer L., Amante, John J., Zhu, Lihua Julie, Wang, Mengdie, Walmsley, Charlotte S., FitzGerald, Thomas J., Goel, Hira Lal, Mercurio, Arthur M.
Veröffentlicht 2019Text -
3
Multi-omics profiling establishes the polypharmacology of FDA Approved CDK4/6 inhibitors and the potential for differential clinical activity von Hafner, Marc, Mills, Caitlin Elizabeth, Subramanian, Kartik, Chen, Chen, Chung, Mirra, Boswell, Sarah Ann, Everley, Robert A., Liu, Changchang, Walmsley, Charlotte Sanden, Juric, Dejan, Sorger, Peter Karl
Veröffentlicht 2019Text -
4
An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression von Yu, Ling, Allen, Read, Jia, Lin, Sun, Ting, Isakoff, Steven J., Scherrer-Crosbie, Marielle, Kehlmann, Allison M., Zheng, Hui, Ly, Amy, Walmsley, Charlotte S., Hesler, Katherine, Varasteh, Ava N., Pinto, Christopher J., McLoughlin, Daniel E., Wu, Wenjin, Wang, Xinhui
Veröffentlicht 2022Text -
5
Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer von Pereira, Bernard, Chen, Christopher T., Goyal, Lipika, Walmsley, Charlotte, Pinto, Christopher J., Baiev, Islam, Allen, Read, Henderson, Laura, Saha, Supriya, Reyes, Stephanie, Taylor, Martin S., Fitzgerald, Donna M., Broudo, Maida Williams, Sahu, Avinash, Gao, Xin, Winckler, Wendy, Brannon, A. Rose, Engelman, Jeffrey A., Leary, Rebecca, Stone, James R., Campbell, Catarina D., Juric, Dejan
Veröffentlicht 2021Text -
6
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer von Coates, James T., Sun, Sheng, Leshchiner, Ignaty, Thimmiah, Nayana, Martin, Elizabeth E., McLoughlin, Daniel, Danysh, Brian P., Slowik, Kara, Jacobs, Raquel A., Rhrissorrakrai, Kahn, Utro, Filippo, Levovitz, Chaya, Denault, Elyssa, Walmsley, Charlotte S., Kambadakone, Avinash, Stone, James R., Isakoff, Steven J., Parida, Laxmi, Juric, Dejan, Getz, Gad, Bardia, Aditya, Ellisen, Leif W.
Veröffentlicht 2021Text -
7
EGFR inhibition potentiates FGFR inhibitor therapy and overcomes resistance in FGFR2 fusion-positive cholangiocarcinoma von Wu, Qibiao, Zhen, Yuanli, Shi, Lei, Vu, Phuong, Greninger, Patricia, Adil, Ramzi, Merritt, Joshua, Egan, Regina, Wu, Meng-Ju, Yin, Xunqin, Ferrone, Cristina R, Deshpande, Vikram, Baiev, Islam, Pinto, Christopher J, McLoughlin, Daniel E, Walmsley, Charlotte S., Stone, James R, Gordan, John D, Zhu, Andrew X., Juric, Dejan, Goyal, Lipika, Benes, Cyril H., Bardeesy, Nabeel
Veröffentlicht 2022Text -
8
Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers von Klotz, Remi, Thomas, Amal, Teng, Teng, Han, Sung Min, Iriondo, Oihana, Li, Lin, Restrepo-Vassalli, Sara, Wang, Alan, Izadian, Negeen, MacKay, Matthew, Moon, Byoung-San, Liu, Kevin J., Ganesan, Sathish Kumar, Lee, Grace, Kang, Diane S., Walmsley, Charlotte S., Pinto, Christopher, Press, Michael F., Lu, Wange, Lu, Janice, Juric, Dejan, Bardia, Aditya, Hicks, James, Salhia, Bodour, Attenello, Frank, Smith, Andrew D., Yu, Min
Veröffentlicht 2019Text